Cholesterol Newswire

Comprehensive Real-Time News Feed for Cholesterol.

Results 1 - 20 of 555 in Cholesterol

  1. Cutting down on prescription drug costsRead the original story w/Photo

    4 hrs ago | WPTV Local News

    ... dosage, and zip code so you can find the best price. It even works with generics. Lipitor helps lower your cholesterol. The generic version is $49.99 at Target. Punch it into GoodRx and you can cut your price to $15.91. The website even gives you ...

    Comment?

  2. A summary and critical assessment of the 2013 ACC/AHA guideline on...Read the original story

    8 hrs ago | CiteULike

    A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps. The American College of Cardiology/American Heart Association Task Force on Practice Guidelines has recently released the new cholesterol treatment guideline.

    Comment?

  3. Cholesterol-lowering statin drugs raise risk of cataracts, new study suggestsRead the original story w/Photo

    11 hrs ago | National Post

    The millions of Canadians taking cholesterol-lowering statin drugs are at heightened risk of contracting cataracts, concludes a new study that adds fuel to heated debate over one of the world's most widely used medications. People on statins are as much as 30% more likely to develop the eye disease than those not taking the pills, suggested the University of British Columbia analysis of hundreds of thousands of patients in U.S. and Canadian health databases.

    Comment?

  4. Sanofi And Regeneron's Cholestrol Drug RaceRead the original story w/Photo

    12 hrs ago | International Business Times

    Sanofi and Regeneron may have a month's headstart on the market before facing competition from Amgen for their cholesterol drug. Sanofi and Regeneron announced on Monday that FDA had accepted for priority review the Biologics License Application for alirocumab, their PCSK9 inhibitor.

    Comment?

  5. The One Thing Pfizer, Inc. Shareholders Should Worry About, and One They Shouldn'tRead the original story w/Photo

    23 hrs ago | The Motley Fool

    ... that it'll experience a negative impact of $3.5 billion from expected product exclusivity losses. Pfizer's cholesterol-fighting drug Lipitor, the former best-selling drug in the world, continues to face generic drug pressure in the U.S., and saw its ...

    Comment?

  6. Cholesterol Drug Alirocumab (Praluent) Wins - Priority Review' DesignationRead the original story

    Tuesday | P&T Community

    ... via subcutaneous injection. By inhibiting PCSK9, a determinant of circulating low-density lipoprotein cholesterol (LDL-C) levels in the blood, alirocumab has been shown in preclinical studies to increase the number of LDL receptors on hepatocytes, ...

    Comment?

  7. statin drugsRead the original story

    Feb 29, 2012 | InteliHealth

    Statins are a group of drugs prescribed to lower cholesterol, protect against damage from coronary-artery disease and prevent heart attack. Should you be taking statins? Statins are a group of drugs prescribed to lower cholesterol, protect against damage from coronary-artery disease and prevent heart attack.

    Comment?

  8. High cholesterol in 30s, 40s, increases later risk of heart diseaseRead the original story w/Photo

    Monday Jan 26 | PhysOrg Weblog

    But new findings from researchers at the Duke Clinical Research Institute suggest that even slightly high cholesterol levels in otherwise healthy adults between the ages of 35 and 55 can have long-term impacts on their heart health, with every decade of high cholesterol increasing their chances of heart disease by 39 percent. The findings are published in the American Heart Association journal Circulation .

    Comment?

  9. Sanofi and Regeneron Gain an Edge in Cholesterol Drug RaceRead the original story

    Monday Jan 26 | The Washington Post

    The U.S. Food and Drug Administration has until July 24 to make a decision on the companies' application to market their jointly developed drug alirocumab, Regeneron and Sanofi said in a statement. Amgen Inc. is developing a competing drug, evolocumab, that's scheduled to get an FDA ruling by Aug. 27. The drugs belong to a class called PCSK9 inhibitors that can drastically cut levels of bad, or LDL, cholesterol associated with cardiovascular disease.

    Comment?

  10. Sanofi And Regeneron Leapfrog Amgen In New Cholesterol Drug RaceRead the original story w/Photo

    Sunday Jan 25 | Forbes.com

    ... Monday Sanofi and Regeneron leapfrogged their rival Amgen to gain leadership in the race to bring a new class of cholesterol drugs to market. The new development could potentially give Sanofi and Regeneron a month on the market by itself before ...

    Comment?

  11. Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug RaceRead the original story

    Sunday Jan 25 | The Washington Post

    Regeneron Pharmaceuticals Inc. and Sanofi may get a head start on their biggest competitor in bringing a new class of cholesterol drugs to the U.S. market. The U.S. Food and Drug Administration has until July 24 to make a decision on the companies' application to market their jointly developed drug alirocumab, Regeneron and Sanofi said in a statement.

    Comment?

  12. Regeneron/Sanofi cholesterol drug gets FDA priority reviewRead the original story

    Sunday Jan 25 | Reuters

    Regeneron Pharmaceuticals on Monday said U.S. health regulators accepted its application to review a potent cholesterol drug on a priority basis, potentially giving it the upper hand in a fierce race with Amgen to bring a new medicine from the promising class to market. Regeneron, which is developing the drug, alirocumab, in partnership with Sanofi, said the target date for a Food and Drug Administration approval decision was July 24, following a six-month review period.

    Comment?

  13. Sore arm persists weeks after flu shotRead the original story w/Photo

    Friday Jan 16 | Seattle Times

    ... as well as leg weakness and trouble walking. Q: I love grapefruit. I have been prescribed simvastatin for high cholesterol, and I am not supposed to eat grapefruit or drink grapefruit juice while I am on this drug. Is there any way to control my ...

    Comment?

  14. Protecting heart surgery patients' kidney health with high-dose statinRead the original story w/Photo

    Thursday Jan 22 | Medical News Today

    ... more information, please read our terms of use . Find out about statins, a group of medicines used to lower LDL cholesterol levels in the blood. Learn about how they work, together with their benefits and side effects.

    Comment?

  15. Is your cholesterol really too high?Read the original story w/Photo

    Tuesday Jan 20 | Inside Bay Area

    There is an International Network of Cholesterol Skeptics - a group of scientists, physicians, other academicians and science writers from various countries - who offer this food for thought.

    Comment?

  16. Is your cholesterol really too high?Read the original story w/Photo

    Tuesday Jan 20 | Inside Bay Area

    There is an International Network of Cholesterol Skeptics - a group of scientists, physicians, other academicians and science writers from various countries - who offer this food for thought.

    Comment?

  17. Lipitor Lawsuit News: Lipitor Lawsuits Conference Scheduled For This...Read the original story

    Tuesday Jan 20 | Personal Injury Law News

    Lipitor Lawsuits Pending In A Multidistrict Litigation In The U.S. District Court, District of South Carolina Allege That Plaintiffs Who Use The Cholesterol-Lowering Medication Develop Type 2 Diabetes.

    Comment?

  18. This List of Exotic Teas From Around the World Will Amaze YouRead the original story w/Photo

    Monday Jan 19 | Lifehack.org

    For thousands of years the Eastern world has deemed tea a crucial part of their culture, believing that consuming tea would bring happiness, health and wisdom. Only recently though, has the West begun waking up to the great benefits of tea! Recent studies have concluded that some teas may encourage weight loss and lower cholesterol, help prevent illnesses, such as some cancers, heart disease, and diabetes, and bring about improved mental alertness.

    Comment?

  19. High-dose statin may protect heart surgery patients' kidney healthRead the original story w/Photo

    Tuesday Jan 20 | PhysOrg Weblog

    ... due to severe hepatic injury, according to a study published in the January ... High doses of a popular cholesterol-lowering drug significantly reduced the rate of acute kidney injury caused by dye used in imaging in acute coronary syndrome patients ...

    Comment?

  20. Hospitalized for pneumonia? Your risk of cardiovascular disease is higherRead the original story w/Photo

    Tuesday Jan 20 | PhysOrg Weblog

    ... for the elderly and those with other risk factors for cardiovascular disease, such as diabetes, smoking and high cholesterol." "Second, once pneumonia has occurred, physicians should develop a care plan understanding that these patients are more ...

    Comment?